Jazz Pharmaceuticals Announces CEO Succession Plan
Jazz Pharmaceuticals(JAZZ) Prnewswire·2024-12-16 21:05Bruce Cozadd, Co-Founder, Chairperson and CEO, Plans to Retire as CEO Upon Appointment of Successor by the End of 2025; Will Continue as Chair of the BoardMr. Cozadd Has Led Growth of Company from Founding to $4 Billion+ in 2024 Expected Total RevenueBoard Will Lead Comprehensive Internal and External Search for New CEO; Intended to be Completed in 2025 DUBLIN, Dec. 16, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Bruce Cozadd, Co-Founder, Chairperson and Chief Executive ...